Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 133

Results For "RET"

1730 News Found

TwistPak: Mixing platform for swine vaccines brings convenience and flexibility
Biotech | May 13, 2022

TwistPak: Mixing platform for swine vaccines brings convenience and flexibility

Boehringer Ingelheim continues to innovate to enhance the customer experience and improve animal health and well-being


Jonathan Peacock elected Chairman of the Board of Directors of Avantor
People | May 13, 2022

Jonathan Peacock elected Chairman of the Board of Directors of Avantor

Peacock also serves as a Director and Chair of the Audit and Finance Committee of UCB SA, a biopharmaceutical company focusing on neurology and immunology


Mawi DNA Technologies launches NextSWAB for Covid-19 test results
Biotech | May 12, 2022

Mawi DNA Technologies launches NextSWAB for Covid-19 test results

NextSWAB is currently optimized for nasal sample collection with validation for other sample types ongoing


First patient dosed with antiepileptic drug candidate CB03 in a first-in-human Phase I trial
Biotech | May 12, 2022

First patient dosed with antiepileptic drug candidate CB03 in a first-in-human Phase I trial

CB03 is a candidate drug for the treatment of refractory epilepsy, independently developed by Zhimeng


Ascletis announces U.S. IND approval of ASC22 for HIV patients
Biotech | May 11, 2022

Ascletis announces U.S. IND approval of ASC22 for HIV patients

ASC22 (Envafolimab) is a subcutaneously administered single-domain antibody against PD-L1 and has the potential to restore virus-specific immune responses in patients with chronic viral infection


New nirsevimab data analyses reinforce efficacy against RSV
Biotech | May 11, 2022

New nirsevimab data analyses reinforce efficacy against RSV

Nirsevimab is the first investigational immunization designed to protect all infants across the RSV season with a single dose


Pfizer to acquire Biohaven Pharmaceuticals for US $ 11.6 billion
Biotech | May 10, 2022

Pfizer to acquire Biohaven Pharmaceuticals for US $ 11.6 billion

Pfizer to commercialize NURTEC ODT (rimegepant), an innovative compound for the prevention and acute treatment of migraine, a condition with high unmet need


Strengthening the access to rare disease treatment in India
Healthcare | May 09, 2022

Strengthening the access to rare disease treatment in India

Takeda and United Nations Global Compact Network of India (UNGCNI) join hands


Premas Biotech appoints Saumen Chakraborty to its Board
People | May 09, 2022

Premas Biotech appoints Saumen Chakraborty to its Board

Saumen is a postgraduate in management from IIM, Ahmedabad and an executive fellow in management from ISB, Hyderabad


Aadi Bioscience announces collaborations with next generation sequencing leaders
Biotech | May 09, 2022

Aadi Bioscience announces collaborations with next generation sequencing leaders

The company enters into collaborations with leading next-generation sequencing (NGS) companies to facilitate trial enrollment for PRECISION 1, the Company’s Phase 2 registrational trial